Nov 16, 2022

GNS Announces Oral Poster Presentation and Abstract at CTAD

The 15th annual Clinical Trials on Alzheimer’s Disease (CTAD) will be held in San Francisco on November 29 – December 2, 2022.

GNS today announced an oral poster presentation and an abstract highlighting insight from the Gemini Digital Twin model in Alzheimer Disease.

Oral Poster Presentation:
Friday, December 2nd from 8am to 5pm PT.

Abstract Title: Causal in silico patient models can inform Alzheimer’s disease patient identification and endpoint selection for early-stage clinical trials

Poster #158

The poster and abstract will be made available on the CTAD website following the presentations at the conference.

For more information on CTAD Conference, please visit

You want to know more? Reach out and let us know if you’d like to schedule a meeting beforehand and discuss drug discovery partnership opportunities.